Please login to the form below

Not currently logged in
Email:
Password:

Adobe CEO joins Pfizer board

Shantanu Narayen joins corporate governance and science and technology committees

Pfizer Shantanu NarayenThe CEO of software giant Adobe Systems has joined pharma company Pfizer as a member of its board of directors.

Shantanu Narayen has been CEO of Adobe since 2007, having previously served as chief operating officer, executive VP of worldwide products and senior VP of product development at the company, which markets products such as PhotoShop and Acrobat.

He joins the corporate governance and science and technology committees of Pfizer's board and will use his background in technology to guide Pfizer's strategy going forward.

“The addition of Shantanu Narayen to our board helps ensure that Pfizer will continue to benefit from a diversity of experience,” said Ian Read, Pfizer's chairman and CEO.

In addition to his role at Adobe, Narayen is a member of the US President's management advisory board; a director of computer company Dell and president of the Adobe Foundation, which funds philanthropic initiatives around the world.

4th October 2013

From: Sales, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...
white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics